283.52 USD
↗ 3.11 (1.11%)AT CLOSE (03:59 PM EST)
Johnson & Johnson
JNJNYSE • USD
283.90
↗ 0.38 (0.13%)
POST MARKET (AS OF 08:00 PM EST)
Post Market
AS OF 08:00 PM EST
283.90
↗ 0.38 (0.13%)
Market: CLOSED
Johnson & Johnson (JNJ) trades at $283.90 per share. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, JNJ trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 12, 2026.
Open?$284.38
High?$286.08
Low?$281.00
Prev. Close?$280.41
Volume?8.8M
Avg. Volume?7.8M
VWAP?$284.08
Rel. Volume?1.13x
Bid / Ask
Bid?$283.49 × 120
Ask?$283.90 × 40
Spread?$0.41
Midpoint?$283.70
Valuation & Ratios
Market Cap?675.0B
Shares Out?2.4B
Float?2.4B
Float %?98.7%
P/E Ratio?41.94
P/B Ratio?8.28
EPS?$6.69
Dividend?1.88%
Ex-Dividend?2026-11-24
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Themes
Employees
140.8K
Market Cap
675.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?99
Momentum?48
Short Sent.?84
Piotroski F-Score?3/9Weak
Altman Z-Score?5.61Safe
Confidence?60%Moderate
Short InterestLow
Short % of Float?0.72%Low
Short Interest?17.1M
Days to Cover?2.4
Free Float2.4B
Avg Daily Volume7.1M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.02Adequate
Quick Ratio?0.74Weak
Cash Ratio?0.30Low
Debt/Equity?0.55Moderate
ValuationRICHLY VALUEDvs 9 peers + S&P 500
Score44/100
P/E?41.9PRICEY▾
Peers63
S&P17
P/B?8.28HIGH▾
Peers50
S&P23
P/S?6.80FAIR▾
Peers50
S&P18
P/FCF?33.4FAIR▾
Peers38
S&P24
EV/EBITDA?21.2HIGH▾
Peers50
S&P22
EV/Sales?7.07HIGH▾
Peers50
S&P20
Returns & Efficiency
ROE?19.7%STRONG▾
Peers63
S&P65
ROA?8.2%STRONG▾
Peers75
S&P66
Cash Flow & Enterprise
FCF?$20.2B
Enterprise Value?$702.8B
Fundamentals ratios updated end of day